Predictive values of early suppression of tumorigenicity 2 for acute GVHD and transplant-related complications after allogeneic stem cell transplantation: prospective observational study

Ayako Matsumura(Yokohama City University), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Shin Fujisawa(Yokohama City University Medical Center), Kenji Matsumoto(RIKEN Center for Brain Science), Takayoshi Tachibana(Yokohama City University), Hiroyuki Takahashi(Yokohama City University), Maki Hagihara(Yokohama City University Hospital), Yoshimi Ishii(Yokohama City University Medical Center), Kenji Motohashi(Yokohama City University Medical Center), Wataru Yamamoto(Yokohama City University Medical Center), Ayumi Numata(Yokohama City University Medical Center), Satoshi Koyama(Yokohama City University), Yuki Nakajima(Fujisawa City Hospital), Megumi Koyama(Yokohama City University Medical Center), Takuya Miyazaki(Kanagawa Prefectural Hospital Organization), Taiki Ando(Kanagawa Prefectural Hospital Organization)
Turkish Journal of Hematology
August 29, 2019
Cited by 10


Related Papers